All Stories

  1. Parainfluenza Fusion Peptide Promotes Membrane Fusion by Assembling into Oligomeric Porelike Structures
  2. The antimetastatic breast cancer activity of the viral protein‐derived peptide vCPP2319 as revealed by cellular biomechanics
  3. Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide
  4. Exosomes and Brain Metastases: A Review on Their Role and Potential Applications
  5. Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening
  6. Conjugation of a Blood Brain Barrier Peptide Shuttle to an Fc Domain for Brain Delivery of Therapeutic Biomolecules
  7. Penetrating the Blood-Brain Barrier with New Peptide–Porphyrin Conjugates Having anti-HIV Activity
  8. Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects
  9. Integrative Human Biochemistry
  10. Anti-HIV-1 Activity of pepRF1, a Proteolysis-Resistant CXCR4 Antagonist Derived from Dengue Virus Capsid Protein
  11. Effects of Diabetes on Microcirculation and Leukostasis in Retinal and Non-Ocular Tissues: Implications for Diabetic Retinopathy
  12. The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization
  13. DPepH3, an Improved Peptide Shuttle for Receptor-independent Transport Across the Blood-Brain Barrier
  14. Antifungal and anti-biofilm activity of designed derivatives from kyotorphin
  15. Can citation metrics predict the true impact of scientific papers?
  16. Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?
  17. Pharmaceutical Innovations: The Grand Challenges Ahead
  18. Enfuvirtide-Protoporphyrin IX Dual-Loaded Liposomes: In Vitro Evidence of Synergy against HIV-1 Entry into Cells
  19. Lidocaine turns the surface charge of biological membranes more positive and changes the permeability of blood-brain barrier culture models
  20. Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix–Loop–Helix Peptides with Cell Penetrating and Tumor Suppressor Properties
  21. Structural determinants conferring unusual long life in human serum to rattlesnake‐derived antimicrobial peptide Ctn[15‐34]
  22. Optical coherence tomography angiography study of the retinal vascular plexuses in type 1 diabetes without retinopathy
  23. Synthesis and Characterization of Peptide–Chitosan Conjugates (PepChis) with Lipid Bilayer Affinity and Antibacterial Activity
  24. A Protocol to Evaluate Retinal Vascular Response Using Optical Coherence Tomography Angiography
  25. The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms
  26. Bacteriocins as Anticancer Peptides: A Biophysical Approach
  27. Fast NMR method to probe solvent accessibility and disordered regions in proteins
  28. Plant defensin PvD1 modulates the membrane composition of breast tumour-derived exosomes
  29. Designing of Artificial Peptides for an Improved Antiviral Activity
  30. Structure–Stability–Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles
  31. Effective in Vivo Targeting of Influenza Virus through a Cell-Penetrating/Fusion Inhibitor Tandem Peptide Anchored to the Plasma Membrane
  32. Biologically active peptides linked to antibody fragments
  33. Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15–34), antimicrobial peptides from rattlesnake venom
  34. A New Noncanonical Anionic Peptide That Translocates a Cellular Blood–Brain Barrier Model
  35. Neuropeptide Kyotorphin Impacts on Lipopolysaccharide-Induced Glucocorticoid-Mediated Inflammatory Response. A Molecular Link to Nociception, Neuroprotection, and Anti-Inflammatory Action
  36. New Potent Membrane-Targeting Antibacterial Peptides from Viral Capsid Proteins
  37. Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance
  38. Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX
  39. Novel Peptides Derived from Dengue Virus Capsid Protein Translocate Reversibly the Blood–Brain Barrier through a Receptor-Free Mechanism
  40. Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides
  41. Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives
  42. siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model
  43. Challenging metastatic breast cancer with the natural defensinPvD1
  44. Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers Staphylococcus aureus isolates
  45. In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence
  46. Bioorthogonal Strategy for Bioprocessing of Specific-Site-Functionalized Enveloped Influenza-Virus-Like Particles
  47. Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
  48. Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors
  49. Fusing simulation and experiment: The effect of mutations on the structure and activity of the influenza fusion peptide
  50. Endothelium-Mediated Action of Analogues of the Endogenous Neuropeptide Kyotorphin (Tyrosil-Arginine): Mechanistic Insights from Permeation and Effects on Microcirculation
  51. Structural Studies of a Lipid-Binding Peptide from Tunicate Hemocytes with Anti-Biofilm Activity
  52. A Rapid and Quantitative Flow Cytometry Method for the Analysis of Membrane Disruptive Antimicrobial Activity
  53. Amidated and Ibuprofen-Conjugated Kyotorphins Promote Neuronal Rescue and Memory Recovery in Cerebral Hypoperfusion Dementia Model
  54. Anticancer Peptides: Prospective Innovation in Cancer Therapy
  55. Antibody Approaches To Treat Brain Diseases
  56. Improvement of the pharmacological properties of amidated kyotorphin by means of iodination
  57. Dps fromDeinococcus radiodurans: oligomeric forms of Dps1 with distinct cellular functions and Dps2 involved in metal storage
  58. The anti-inflammatory action of the analgesic kyotorphin neuropeptide derivatives: insights of a lipid-mediated mechanism
  59. Understanding Dengue Virus Capsid Protein Interaction with Key Biological Targets
  60. Effects of singlet oxygen generated by a broad-spectrum viral fusion inhibitor on membrane nanoarchitecture
  61. Rethinking the capsid proteins of enveloped viruses: multifunctionality from genome packaging to genome transfection
  62. Mining viral proteins for antimicrobial and cell-penetrating drug delivery peptides
  63. Shifting gear in antimicrobial and anticancer peptides biophysical studies: from vesicles to cells
  64. Monitoring antibacterial permeabilization in real time using time-resolved flow cytometry
  65. Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics
  66. Integrative Human Biochemistry
  67. Introduction to Metabolism
  68. The Regulation of Metabolisms
  69. Regulation and Integration of Metabolism During Physical Activity
  70. The Families of Biological Molecules
  71. The Chemistry and Physics of Life
  72. Catabolism of the Major Biomolecules
  73. Introduction: Life Is Made of Molecules!
  74. Energy Conservation in Metabolism: The Mechanisms of ATP Synthesis
  75. Regulation and Integration of Metabolism During Hypoglycemia
  76. Metabolic Responses to Hyperglycemia: Regulation and Integration of Metabolism in the Absorptive State
  77. Correlation between membrane translocation and analgesic efficacy in kyotorphin derivatives
  78. Enhanced HIV Fusion Inhibitors Efficacy Requires Membrane Affinity and Exposure of the Pocket Binding Domain of C34 Derivatives
  79. Receptors and routes of dengue virus entry into the host cells
  80. The interaction of antibodies with lipid membranes unraveled by fluorescence methodologies
  81. Understanding Dengue Virus Capsid Protein Disordered N-Terminus and pep14-23-Based Inhibition
  82. The Use of Visual Analog Scales to Compare Pain Between Patients With Alzheimer’s Disease and Patients Without Any Known Neurodegenerative Disease and Their Caregivers
  83. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria
  84. Singlet oxygen effects on lipid membranes: implications for the mechanism of action of broad-spectrum viral fusion inhibitors
  85. Cell-penetrating peptides: A tool for effective delivery in gene-targeted therapies
  86. The Mechanisms and Quantification of the Selective Permeability in Transport Across Biological Barriers: the Example of Kyotorphin
  87. Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure
  88. Dengue virus capsid protein interacts specifically with very low-density lipoproteins
  89. Dengue Virus Capsid Protein Delivers Nucleic Acids Intracellularly
  90. Dengue Virus Capsid Protein Interacts Specifically with Very Low-Density Lipoproteins
  91. New Broad-Spectrum Viral Fusion Inhibitors Act by Deleterious Effect on the Viral Membrane through the Production Singlet Oxygen Molecules
  92. Intracellular Nucleic Acid Delivery by the Supercharged Dengue Virus Capsid Protein
  93. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action
  94. rBPI21 interacts with negative membranes endothermically promoting the formation of rigid multilamellar structures
  95. The Antimicrobial Activity of Sub3 is Dependent on Membrane Binding and Cell-Penetrating Ability
  96. N-Terminal AH2 segment of protein NS4B from hepatitis C virus. Binding to and interaction with model biomembranes
  97. Decoding distinct membrane interactions of HIV-1 fusion inhibitors using a combined atomic force and fluorescence microscopy approach
  98. Peptides as models for the structure and function of viral capsid proteins: Insights on dengue virus capsid
  99. A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion
  100. Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
  101. Side-effects of analgesic kyotorphin derivatives: advantages over clinical opioid drugs
  102. Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria
  103. Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems
  104. The Dengue Virus Capsid Protein Inhibitor Peptide Pep14-23 becomes Alpha-Helical upon Binding to Negative Lipids
  105. Dengue Virus Capsid Protein Binding to Lipid Droplets and its Inhibition. towards a New Drug Target
  106. From antimicrobial to anticancer peptides. A review
  107. Neuropeptide Kyotorphin (Tyrosyl-Arginine) has Decreased Levels in the Cerebro-Spinal Fluid of Alzheimer’s Disease Patients: Potential Diagnostic and Pharmacological Implications
  108. Arginine-rich self-assembling peptides as potent antibacterial gels
  109. Antimicrobial Peptide rBPI21: A Translational Overview from Bench to Clinical Studies
  110. Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
  111. Anticancer Peptide SVS-1: Efficacy Precedes Membrane Neutralization
  112. Phosphatidylethanolamine Binding Is a Conserved Feature of Cyclotide-Membrane Interactions
  113. The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif
  114. A Focus on Glucose-Mediated Drug Delivery to the Central Nervous System
  115. Peptide Drug Discovery and Development: Translational Research in Academia and Industry. Edited by Miguel Castanho and Nuno C. Santos.
  116. Antimicrobial properties of analgesic kyotorphin peptides unraveled through atomic force microscopy
  117. Electron/proton coupling in biological energy transduction
  118. Short Stories - on Antimicrobial Peptides that are Too Short to Span the Membrane
  119. Biomedical applications of dipeptides and tripeptides
  120. Interaction of antimicrobial peptides, BP100 and pepR, with model membrane systems as explored by brownian dynamics simulations on a coarse-grained model
  121. The Researching, Teaching, and Learning Triangle
  122. The Mechanism of Action of Antimicrobial Peptides: Lipid Vesicles vs. Bacteria
  123. Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Synergistically Potentiates Peptide-Membrane Interaction
  124. Relating Molecular-Level Events with Bacterial Killing by Antimicrobial Peptides
  125. Translocating the blood-brain barrier using electrostatics
  126. Biophysical characterization of polymyxin b interaction with LPS aggregates and membrane model systems
  127. The Application of Biophysical Techniques to Study Antimicrobial Peptides
  128. Decoding Distinct Membrane Interactions of HIV-1 Inhibitors Enfuvirtide and T-1249 using Atomic Force Microscopy Combined with Fluorescence Methodologies
  129. Prediction of Antibacterial Activity from Physicochemical Properties of Antimicrobial Peptides
  130. Dengue Virus Capsid Protein Binding to Hepatic Lipid Droplets (LD) Is Potassium Ion Dependent and Is Mediated by LD Surface Proteins
  131. Peptide Drug Discovery and Development
  132. Chemical Conjugation of the Neuropeptide Kyotorphin and Ibuprofen Enhances Brain Targeting and Analgesia
  133. Inhibition of nociceptive responses after systemic administration of amidated kyotorphin
  134. Decoding the Membrane Activity of the Cyclotide Kalata B1
  135. Characterization of the Interaction of the Dengue Virus Capsid Protein with Lipid Droplets
  136. rBPI21 Causes (HEMI)Fusion and Leakage of Membranes and Promotes Massive Lipopolysaccharide Aggregation
  137. Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes
  138. Using zeta-potential measurements to quantify peptide partition to lipid membranes
  139. Cationic liposomes are possible drug-delivery systems for HIV fusion inhibitor sifuvirtide
  140. The role of blood cell membrane lipids on the mode of action of HIV-1 fusion inhibitor sifuvirtide
  141. Quantitative assessment of peptide–lipid interactions.
  142. Drug–lipid interaction evaluation: why a 19th century solution?
  143. Is PrP(106-126) Fragment Involved in the Membrane Activity of the Prion Protein?
  144. Escherichia coliCell Surface Perturbation and Disruption Induced by Antimicrobial Peptides BP100 and pepR
  145. Unravelling the molecular basis of the selectivity of the HIV-1 fusion inhibitor sifuvirtide towards phosphatidylcholine-rich rigid membranes
  146. Is PrP(106-126) Fragment Involved in the Membrane Activity of the Prion Protein?
  147. HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes
  148. In Vitro Blood-Brain Barrier Models – Latest Advances and Therapeutic Applications in a Chronological Perspective
  149. Membrane-Active Peptides: Methods and Results on Structure and Function
  150. Fast membrane association is a crucial factor in the peptide pep-1 translocation mechanism: A kinetic study followed by surface plasmon resonance
  151. Unraveling the Molecular Basis of the Selectivity of the HIV-1 Fusion Inhibitor Sifuvirtide Towards Phosphatidylcholine-Rich Rigid Membranes
  152. rBPI21 Promotes Lipopolysaccharide Aggregation and Exerts Its Antimicrobial Effects by (Hemi)fusion of PG-Containing Membranes
  153. Interaction of the Dengue Virus Fusion Peptide with Membranes Assessed by NMR: The Essential Role of the Envelope Protein Trp101 for Membrane Fusion
  154. The Toxicity of Prion Protein Fragment PrP(106−126) is Not Mediated by Membrane Permeabilization as Shown by a M112W Substitution
  155. Interactions of HIV-1 Antibodies 2F5 and 4E10 with a gp41 Epitope Prebound to Host and Viral Membrane Model Systems
  156. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
  157. Synergistic Effects of the Membrane Actions of Cecropin-Melittin Antimicrobial Hybrid Peptide BP100
  158. Human Erythrocytes And Mononuclear Leukocytes Are Capable Of Concentrating HIV-1 Fusion Inhibitor Peptides In Their Membranes
  159. Fold-Unfold Transitions in the Selectivity and Mechanism of Action of the N-Terminal Fragment of the Bactericidal/Permeability-Increasing Protein (rBPI21)
  160. PrP(106-126) Does Not Interact with Membranes under Physiological Conditions
  161. Sifuvirtide Screens Rigid Membrane Surfaces. Establishment of a Correlation between Efficacy and Membrane Domain Selectivity among HIV Fusion Inhibitor Peptides
  162. Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2
  163. Translocation or membrane disintegration? Implication of peptide–membrane interactions in pep-1 activity
  164. Enfuvirtide effects on human erythrocytes and lymphocytes functional properties
  165. Biophysics meets membrane-active peptides
  166. Interaction between dengue virus fusion peptide and lipid bilayers depends on peptide clustering
  167. What can light scattering spectroscopy do for membrane-active peptide studies?
  168. Molecular interaction studies of peptides using steady-state fluorescence intensity. Static (de)quenching revisited
  169. The influence of cholesterol on the interaction of HIV gp41 membrane proximal region-derived peptides with lipid bilayers
  170. Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturation
  171. Shiga toxin B-subunit sequential binding to its natural receptor in lipid membranes
  172. How to address CPP and AMP translocation? Methods to detect and quantify peptide internalizationin vitroandin vivo(Review)
  173. Energy-independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1
  174. Cell-penetrating peptides and antimicrobial peptides: how different are they?
  175. The membranes’ role in the HIV-1 neutralizing monoclonal antibody 2F5 mode of action needs re-evaluation
  176. Chiral Recognition ofD-Kyotorphin by Lipidic Membranes: Relevance Toward Improved Analgesic Efficiency
  177. Omiganan Pentahydrochloride in the Front Line of Clinical Applications of Antimicrobial Peptides
  178. Conformational and Orientational Guidance of the Analgesic Dipeptide Kyotorphin Induced by Lipidic Membranes:  Putative Correlation toward Receptor Docking
  179. An Insight on the Leading HIV Entry Inhibitors
  180. Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions
  181. Miguel A.R.B. Castanho
  182. Lipid membrane-induced optimization for ligand–receptor docking: recent tools and insights for the “membrane catalysis” model
  183. Translocation of β-Galactosidase Mediated by the Cell-Penetrating Peptide Pep-1 into Lipid Vesicles and Human HeLa Cells Is Driven by Membrane Electrostatic Potential†
  184. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides
  185. Overview of Common Spectroscopic Methods to Determine the Orientation/Alignment of Membrane Probes and Drugs in Lipidic Bilayers
  186. Environmental factors that enhance the action of the cell penetrating peptide pep-1
  187. Developing students' awareness of public understanding of science: A matter of survival?
  188. Lipidic Membranes Are Potential “Catalysts” in the Ligand Activity of the Multifunctional Pentapeptide Neokyotorphin
  189. Cholesterol modulates maculosin's orientation in model systems of biological membranes
  190. HIV Fusion Inhibitor Peptide T-1249 Is Able To Insert or Adsorb to Lipidic Bilayers. Putative Correlation with Improved Efficiency
  191. Consequences of Nonlytic Membrane Perturbation to the Translocation of the Cell Penetrating Peptide Pep-1 in Lipidic Vesicles†
  192. Does Aliphatic Chain Length Influence Carbocyanines' Orientation in Supported Lipid Multilayers?
  193. Filipin Orientation Revealed by Linear Dichroism. Implication for a Model of Action
  194. What do college life sciences students need to know about knowledge management?
  195. An overview of the biophysical applications of atomic force microscopy
  196. Putative role of membranes in the HIV fusion inhibitor enfuvirtide mode of action at the molecular level
  197. Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods
  198. Evaluation of Lipopolysaccharide Aggregation by Light Scattering Spectroscopy
  199. Lipossomas: a bala mágica acertou?
  200. Teaching Molecular Applications of the Particle-in-a-Ring Model Using Azulene
  201. Brownian dynamics simulation of the unsaturated lipidic molecules oleic and docosahexaenoic acid confined in a cellular membrane
  202. Joint determination by Brownian dynamics and fluorescence quenching of the in-depth location profile of biomolecules in membranes
  203. Revealing the Orientation of Nystatin and Amphotericin B in Lipidic Multilayers by UV−Vis Linear Dichroism
  204. Dealing with the challenges of teaching molecular biophysics to biochemistry majors through an heuristics-based approach
  205. Crude tall-oil sodium salts micellization in aqueous solutions studied by static and dynamic light scattering
  206. A photophysical study of the polyene antibiotic filipin
  207. Conference Report
  208. Meeting Report — Biochemical Education at the University Level, Lisbon, Portugal, October 30−31, 1999
  209. Conformation and dynamic properties of a saturated hydrocarbon chain confined in a model membrane: a Brownian dynamics simulation
  210. Overcoming Angular Dependency When Teaching Light Scattering Using a Spectrofluorometer: The Molecular Weight of Latex Beads
  211. The pentaene macrolide antibiotic filipin prefers more rigid DPPC bilayers: a fluorescence pressure dependence study
  212. Simulation of the distribution and diffusion of a rigid amphipathic particle embedded in a model membrane
  213. Reconstitution of Phospholipid Bilayer by an Atomic Force Microscope Tip
  214. Filipin-Induced Lesions in Planar Phospholipid Bilayers Imaged by Atomic Force Microscopy
  215. Fluorescence quenching data interpretation in biological systems
  216. Continuous particle size distribution analysis with dynamic light scattering
  217. Interaction of the Major Epitope Region of HIV Protein gp41 with Membrane Model Systems. A Fluorescence Spectroscopy Study†
  218. Separating the turbidity spectra of vesicles from the absorption spectra of membrane probes and other chromophores
  219. Structural characterization of organized systems of polysaccharides and phospholipids by light scattering spectroscopy and electron microscopy
  220. Structural characterization (shape and dimensions) and stability of polysaccharide/lipid nanoparticles
  221. Snatos, Nuno C., and Miguel A. R. B. Castanho. 1996. Biophys. J. 71:1641–1650
  222. The Shape, Dimension and Organisation of Maltodextrins Gel Fragments with and without Associated Phospholipids
  223. Teaching light scattering spectroscopy: the dimension and shape of tobacco mosaic virus
  224. The transverse location of the fluorescent probe trans-parinaric acid in lipid bilayers
  225. Filipin fluorescence quenching by spin-labeled probes: studies in aqueous solution and in a membrane model system
  226. Filipin and its interaction with cholesterol in aqueous media studied using static and dynamic light scattering
  227. Fluorescence study of a derivatized diacylglycerol incorporated in model membranes
  228. Rod-like cholesterol micelles in aqueous solution studied using polarized and depolarized dynamic light scattering
  229. Fluorescence study of the macrolide pentaene antibiotic filipin in aqueous solution and in a model system of membranes